The Immunology of Diabetes Society

2020年10月15日-10月18日

北京

The Immunology of Diabetes Society

会议简介

Speech from the organizer

Dear Friends and Colleagues,

Welcome to the  IDS conference, the academic feast of diabetes research. The Immunology of Diabetes Society (IDS) is a scientific society dedicated to improving understanding and treatment of type 1 diabetes. Our Society exists to bring together many strands of scientific endeavour with the goal of better understanding and treatment of type 1 diabetes. These strands include breakdown of tolerance and developmentof autoimmunity, how beta cells are destroyed by the immune system, the nature of the autoantigens recognised by pathogenic T cells, the role of viruses and other environmental factors in triggering and promoting autoimmunity. We are especially focused on clinical trials of new therapies.

Since 1995, the IDS has hold 16 successful international academic meetings. Due to the pandemic of COVID-19, the 17th IDS conference will be held online from Oct 15 to 18, 2020. The registration for the online 17th IDS meeting is free! Pleaes join us for the breaking discoveries in type 1 diabetes.

Zhiguang Zhou, MD PhD

IDS2020 organizing chair


Schedule of meetings

17th IDS Congress Preliminary Agenda (Beijing time)

Day 1 (Oct 15, 2020)

19:00-19:10

 

Opening Ceremony: Anette Ziegler (Germany, 13:00) & Zhiguang Zhou (China)

 

19:10-19:35

Franco Bottazzo   Lecture  (25’)

Ake Lernmark (Sweden, 13:10)

 

Chair

Ezio Bonifacio (Germany, 13:10)

 

19:35-20:50

Session 1  Epigenetics   and Transcriptomics of T1D (75 min)

Key Note Lecture: David Leslie (UK,   12:35)  15’

Epigenetics of T1D: Epiphany or   Epiphenomenon?

 

Chairs

Carani Sanjeevi (Sweden, 13:35), Linda Yip (USA, 4:35am)

Speakers(15’ each)

 

Ranjeny Thomas (Queensland, Australia,   21:35): Identification and therapeutic regulation   of autoantigen-specific responses in pediatric type 1 diabetes)

 

Cong-Yi Wang (China): The implication of   epigenetic factors in the initiation and progression of type 1 diabetes

 

Riitta Lahesmaa (Finland, 14:35): Early detection of immune cell signatures in children developing   beta-cell autoimmunity

 

Questions: 15min

 

20:50-21:00

BREAK 10 min

21:00-22:15

Session Genetic Risk and Heterogeneity of T1D (75min)

 

Key Note Lecture  Steve Rich (USA, 9:00 am) 25’

Advances in the Genetic Basis of Type 1   Diabetes and Application to Population Screening

 

Chairs A G Ziegler   (Germany, 15:00)  Bill Hagopian (USA,   6:00am)

 

Speakers(15’ each)

Tao Yang (China) Characteristics and   heterogeneity of genetics, autoimmune and islet function for adult-onset type   1 diabetes

 

Andrea Steck (USA, 7:00am): Heterogeneity and Prediction of T1D

 

William Hagopian (USA, 6:00am): Applying   Combined Risk Scores using Genetics, Family History and Islet Autoantibodies   in Pediatric Population Screening and Selection for Prevention Trials

 

Questions:   20min

 

CLOSE OF SESSION 22:15      Total 3 hours 15min

 

 

Day 2 (Oct 16, 2020)

19:00-20:30

Session 3 Beta cell in Health and Disease (90 min)

Key Note Lecture 

Tao Xu (China ) 25’

 

Chairs

Zhou Z (China) , Simi   Ahmed (USA, 7:00am)

 

Speakers (15’each)

Helen Thomas (Australia, 21:00): The influence of cytokines and JAK inhibitors on expansion of   antigen-specific T cells

 

Stephan Speier (Germany, 13:00):   In Situ Analysis of Human Islet Pathophysiology in T1D

 

Teresa Mastracci (USA, 7:00am)

 

Questions: 20min

 


20:30-20:40

BREAK 10 min


20:40-21:25

Session 4  Gut Microbiota in T1D  (45 min)

Chairs

Li Wen (USA, 8:40am) James Pearson (UK, 13:40)

Discussant Emma   Hamilton-Williams (Australia, 22:40)

  

Speakers   (15’ each)

 

Michael Knip (Finland, 15:40): Can the T1D Risk Be Modulated Through the Intestinal Microbiome?

 

Yu Liu (China)

 

Questions: 15 min

 


21:25-22:30

Session 5  Adult-Onset Autoimmune Diabetes (65min)

Chairs

David Leslie (UK, 14:25), Zhiguang Zhou (China)

Discussants Toshiaki Hanafusa (Japan, 22:25), Paolo Pozzilli   (Italy, 15:25)

 

Speakers  (15’ each)

Paolo Pozzilli (Italy, 15:25)

Xia Li (China)

Tiina Tuomi (Finland, 16:25)

 

Questions: 20min

 

 

CLOSE OF SESSION 22:15      Total 3 hours 30 min

 

 


Day 3 (Oct 17, 2020)

19:00-20:00

Session 6 Islet Transplantation & Stem Cell Therapy (60   min)

Chairs  

Tom Kay (Australia, 21:00) Susan   Wong (UK, 12:00)

Discussant Philip O’Connell (Australia,   21:00)

 

Speakers   (15’ each)

 

Akihisa Imagawa (Japan, 20:00): Usefulness   of patient-derived iPS cells in fulminant type 1 diabetes

 

Hongkui Deng (China)

 

Qizhi Tang (USA, 4:00am): Islet-infiltrating Tregs in autoimmune diabetes and islet   transplantation

 

Questions: 15 min

 

 


20:00-20:25

 

 

 

 

 

George Eisenbarth   Lecture (25’)

Kevan Herold (USA, 8:00am)

 

Chairs

AG Ziegler (Germany, 14:00)

Marian Rewers (USA, 6:00am)

 


20:25-20:35  

BREAK 10 min 


20:35-22:10

 

Session 7 Immune   Cells in T1D  (95 min)

 

Chairs

Mark Peakman (UK, 13:35), Yufei Xiang (USA, 5:35am)

 

Speakers  (15’ each)

Roberto Mallone (France,   14:35)βeauty   is in the eye of the T-cell beholder

 

Peggy Kendall (USA, 7:35am): Targeting   anti-insulin B cells in T1D

 

Aimin Xu (China): Neutrophil-macrophage   crosstalk in autoimmune diabetes

 

Agnes Lehuen (INSERM, U Paris, France,   14:35): MAIT cells at the crossroad between   microbiota, inflammation and metabolism

 

Questions:   20 min

 


22:10-22:55

 

Session 8  Immune Therapy (45 min)

ChairJay Skyler (USA, 9:10am) Chantal Mathieu   (Belgium, 16:10)

 

 

Speakers   (15’ each)

Colin Dayan (UK, 15:10): JDRF TOMI and the way forward in beta cell preservation in T1D

 

David Rawlings (USA, 7:10am): Gene editing to   generation engineered regulatory T cells for treatment of autoimmune   disorders including T1D

 

Questions: 15 min

 

 

CLOSE OF SESSION 22:55      Total 3 hours 55min

 


Day 4 (Oct 18, 2020)

19:00-20:10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Session 9 Autoimmunity: Advances in Immunology (70min)

Key Note Lecture 

Chen Dong (China) 25’

CD4+ T cells in autoimmunity

 

Chairs

Dirk Homann (Germany, 13:00) Z Zhou (China)

Discussant Lucienne   Chatenoud (France, 13:00)

 

Speakers  (15’ each)

Tetsuro Kobayashi (Japan, 20:00): Distinct   pathological changes of the pancreas in fulminant type 1 diabetes

 

Abdu Hamad (USA, 7:00am)

 

Questions: 15min

 


20:10-20:20

BREAK 10min


20:20-22:20

Special   session incorporating workshops


20:20-21:20

T cell workshop (60’) Eddie James   to organize


21:20-22:20

Antibody Workshop IASP   60’ Peter Achenbach to organize

 

CLOSE OF SESSION 22:20        Total 3 hours 20min

 






 

Time

0400. West coast USA

0500, Mountain time USA

0600 Central USA

0700 Eastern USA

1200 UK

1300 Central European Time

1900 China

2000 Japan

2100 Melbourne, Sydney, Australia



会议日程

会议日期

2020年10月15日 -10月18日

联系我们

  • 13683685401
扫一扫关注公众号

医脉通医学会议